October 1, 2024 Investor Beware: Port Strike Puts Key Stocks And Sectors At Risk
September 30, 2024 Market Movers: Jobs Report and Key Earnings in Focus
September 19, 2024 Federal Reserve’s Aggressive Move Hints At Bold Economic Strategy
Apple: Lock In Gains Before They Evaporate
Tesla Stock: Too Many Unknowns After Robotaxi Event
Tesla: Time And Patience Running Out
The Biggest Problem With Nvidia’s Stock That Everyone Is Missing
October 3, 2024 Your Path to Profits: The Best Trading Platforms for New Traders
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Genprex (GNPX) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: October 14, 2024 (17:38)
Sector: HealthcareThe share price of Genprex, Inc. (GNPX) now
Are you interested in Genprex, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Genprex stock price in 2024, 2025, 2026, 2027, 2028. How much will one Genprex share be worth in 2024 - 2028?
When should I take profit in Genprex stock? When should I record a loss on Genprex stock? What are analysts' forecasts for Genprex stock? What is the future of Genprex stock? We forecast Genprex stock performance using neural networks based on historical data on Genprex stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Genprex stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Genprex shares. This happens once a day.
Historical and forecast chart of Genprex stock
The chart below shows the historical price of Genprex stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Genprex stock price can be found in the table below.
Long-term forecasts by years.
Genprex, Inc. Is a clinical gene therapy company. The company is focused on developing oncology based on its new technology platform, including its initial candidate product, Oncoprex, immunogenotherapy or Oncoprex. Oncoprex consists of a tumor suppressor gene introduced into the cells of a patient, which has an immunomodulatory effect and is thus considered an immunogenic therapy. The gene is one of a number of genes licensed for therapeutic use by the University of Texas MD Anderson Cancer Center (MD Anderson). It is also developing preclinical gene therapy licensed by the University of Pittsburgh Commonwealth Higher Education System, which has the potential to treat type 1 and type 2 diabetes. He is developing his candidate product for use with targeted therapy and immunotherapy for non-small cell lung cancer (NSCLC).
Genprex daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct 16 | 0.33 | 0.33 | 0.34 | 3.91 |
| Oct 17 | 0.33 | 0.32 | 0.34 | 5.73 |
| Oct 18 | 0.33 | 0.32 | 0.34 | 5.17 |
| Oct 19 | 0.32 | 0.31 | 0.32 | 3.96 |
| Oct 20 | 0.32 | 0.32 | 0.33 | 5.28 |
| Oct 21 | 0.33 | 0.32 | 0.34 | 5.45 |
| Oct 22 | 0.32 | 0.32 | 0.33 | 3.88 |
| Oct 23 | 0.32 | 0.32 | 0.33 | 4.25 |
| Oct 24 | 0.32 | 0.32 | 0.33 | 3.15 |
| Oct 25 | 0.32 | 0.31 | 0.33 | 4.23 |
| Oct 26 | 0.32 | 0.32 | 0.32 | 2.43 |
| Oct 27 | 0.32 | 0.32 | 0.33 | 3.67 |
| Oct 28 | 0.33 | 0.32 | 0.33 | 2.30 |
| Oct 29 | 0.34 | 0.33 | 0.35 | 5.88 |
| Oct 30 | 0.34 | 0.33 | 0.35 | 4.08 |
| Oct 31 | 0.35 | 0.34 | 0.35 | 2.97 |
| Nov 01 | 0.36 | 0.35 | 0.37 | 5.93 |
| Nov 02 | 0.37 | 0.36 | 0.37 | 3.84 |
| Nov 03 | 0.37 | 0.36 | 0.37 | 4.01 |
| Nov 04 | 0.37 | 0.36 | 0.37 | 4.32 |
| Nov 05 | 0.37 | 0.36 | 0.38 | 5.63 |
| Nov 06 | 0.38 | 0.37 | 0.39 | 4.01 |
| Nov 07 | 0.37 | 0.37 | 0.38 | 3.00 |
| Nov 08 | 0.38 | 0.37 | 0.39 | 5.23 |
| Nov 09 | 0.37 | 0.37 | 0.38 | 2.47 |
| Nov 10 | 0.39 | 0.38 | 0.39 | 3.78 |
| Nov 11 | 0.37 | 0.36 | 0.38 | 4.64 |
| Nov 12 | 0.36 | 0.36 | 0.37 | 3.09 |
| Nov 13 | 0.37 | 0.36 | 0.38 | 4.76 |
| Nov 14 | 0.36 | 0.36 | 0.37 | 3.89 |
Genprex Daily Price Targets
Genprex Stock Forecast 10-16-2024.
Forecast target price for 10-16-2024: $0.33.
Negative dynamics for Genprex shares will prevail with possible volatility of 3.759%.
Pessimistic target level: 0.33
Optimistic target level: 0.34
Genprex Stock Forecast 10-17-2024.
Forecast target price for 10-17-2024: $0.33.
Negative dynamics for Genprex shares will prevail with possible volatility of 5.419%.
Pessimistic target level: 0.32
Optimistic target level: 0.34
Genprex Stock Forecast 10-18-2024.
Forecast target price for 10-18-2024: $0.33.
Positive dynamics for Genprex shares will prevail with possible volatility of 4.920%.
Pessimistic target level: 0.32
Optimistic target level: 0.34
Genprex Stock Forecast 10-19-2024.
Forecast target price for 10-19-2024: $0.32.
Negative dynamics for Genprex shares will prevail with possible volatility of 3.806%.
Pessimistic target level: 0.31
Optimistic target level: 0.32
Genprex Stock Forecast 10-20-2024.
Forecast target price for 10-20-2024: $0.32.
Positive dynamics for Genprex shares will prevail with possible volatility of 5.019%.
Pessimistic target level: 0.32
Optimistic target level: 0.33
Genprex Stock Forecast 10-21-2024.
Forecast target price for 10-21-2024: $0.33.
Positive dynamics for Genprex shares will prevail with possible volatility of 5.170%.
Pessimistic target level: 0.32
Optimistic target level: 0.34
GNPX (GNPX) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Nov. | 0.35 | 0.32 | 0.38 | 15.21 |
| Dec. | 0.40 | 0.37 | 0.42 | 11.55 |
Genprex forecast for this year
Genprex Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $0.351372. Pessimistic: $0.32. Optimistic: $0.38
Genprex Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $0.401407. Pessimistic: $0.37. Optimistic: $0.42
Genprex (GNPX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.38 | 0.33 | 0.40 | 15.68 |
| Feb | 0.39 | 0.34 | 0.42 | 18.17 |
| Mar | 0.39 | 0.35 | 0.44 | 18.92 |
| Apr | 0.38 | 0.36 | 0.41 | 12.83 |
| May | 0.35 | 0.34 | 0.37 | 9.55 |
| Jun | 0.36 | 0.34 | 0.37 | 7.88 |
| Jul | 0.36 | 0.32 | 0.39 | 17.89 |
| Aug | 0.33 | 0.30 | 0.35 | 12.63 |
| Sep | 0.33 | 0.31 | 0.34 | 8.26 |
| Oct | 0.34 | 0.29 | 0.37 | 20.26 |
| Nov | 0.36 | 0.32 | 0.39 | 16.94 |
| Dec | 0.39 | 0.36 | 0.42 | 12.93 |
Genprex (GNPX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.39 | 0.37 | 0.43 | 15.11 |
| Feb | 0.39 | 0.36 | 0.44 | 18.92 |
| Mar | 0.42 | 0.40 | 0.44 | 9.86 |
| Apr | 0.41 | 0.37 | 0.45 | 17.16 |
| May | 0.40 | 0.38 | 0.44 | 13.85 |
| Jun | 0.38 | 0.36 | 0.41 | 10.75 |
| Jul | 0.38 | 0.36 | 0.41 | 11.75 |
| Aug | 0.37 | 0.34 | 0.39 | 14.50 |
| Sep | 0.38 | 0.34 | 0.40 | 16.74 |
| Oct | 0.43 | 0.39 | 0.48 | 18.22 |
| Nov | 0.40 | 0.37 | 0.45 | 17.07 |
| Dec | 0.42 | 0.40 | 0.46 | 11.98 |
Genprex information and performance
100 CONGRESS AVENUE, SUITE 2000, AUSTIN, TX, US
Market capitalization of the Genprex, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GNPX shares in the company outstanding by the market price of one share.
EBITDA of Genprex is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
